======= WBP2 ======= == Gene Information == * **Official Symbol**: WBP2 * **Official Name**: WW domain binding protein 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23558|23558]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q969T9|Q969T9]] * **Interactions**: [[https://thebiogrid.org/search.php?search=WBP2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20WBP2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606962|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Acts as transcriptional coactivator of estrogen and progesterone receptors (ESR1 and PGR) upon hormone activation (PubMed:16772533). In presence of estrogen, binds to ESR1- responsive promoters (PubMed:16772533). Required for YAP1 coactivation function on PGR activity (PubMed:16772533). Synergizes with WBP2 in enhancing PGR activity (PubMed:16772533). Modulates expression of post-synaptic scaffolding proteins via regulation of ESR1, ESR2 and PGR (By similarity). {ECO:0000250|UniProtKB:P97765, ECO:0000269|PubMed:16772533}. |WWbp| |GRAM| |positive regulation of histone H3-K14 acetylation| |regulation of histone H3-K14 acetylation| |progesterone receptor signaling pathway| |positive regulation of intracellular estrogen receptor signaling pathway| |positive regulation of intracellular steroid hormone receptor signaling pathway| |cellular response to estrogen stimulus| |positive regulation of histone acetylation| |positive regulation of peptidyl-lysine acetylation| |regulation of intracellular estrogen receptor signaling pathway| |positive regulation of protein acetylation| |estrogen receptor binding| |response to progesterone| |regulation of histone acetylation| |regulation of peptidyl-lysine acetylation| |positive regulation of gene expression, epigenetic| |intracellular steroid hormone receptor signaling pathway| |regulation of protein acetylation| |chromatin DNA binding| |response to estrogen| |regulation of intracellular steroid hormone receptor signaling pathway| |positive regulation of histone modification| |positive regulation of chromatin organization| |steroid hormone mediated signaling pathway| |regulation of histone modification| |intracellular receptor signaling pathway| |hormone-mediated signaling pathway| |positive regulation of chromosome organization| |cellular response to steroid hormone stimulus| |regulation of chromatin organization| |response to ketone| |regulation of gene expression, epigenetic| |nuclear chromatin| |transcription coactivator activity| |response to steroid hormone| |regulation of chromosome organization| |RNA polymerase II proximal promoter sequence-specific DNA binding| |cellular response to lipid| |cellular response to organic cyclic compound| |cellular response to hormone stimulus| |positive regulation of organelle organization| |response to lipid| |response to hormone| |response to organic cyclic compound| |response to drug| |positive regulation of cellular component organization| |positive regulation of transcription by RNA polymerase II| |cellular response to endogenous stimulus| |positive regulation of protein modification process| |regulation of organelle organization| |response to endogenous stimulus| |positive regulation of transcription, DNA-templated| |response to oxygen-containing compound| |positive regulation of cellular protein metabolic process| |establishment of protein localization| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of signal transduction| |positive regulation of protein metabolic process| |positive regulation of RNA metabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of protein modification process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp64|Nocodazole 0.2μM R02 exp64]]|2.11| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 7730 * **Expression level (log2 read counts)**: 5.39 {{:chemogenomics:nalm6 dist.png?nolink |}}